These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 30088225

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. MiR-33b inhibits osteosarcoma cell proliferation through suppression of glycolysis by targeting Lactate Dehydrogenase A (LDHA).
    Zheng XM, Xu CW, Wang F.
    Cell Mol Biol (Noisy-le-grand); 2018 Aug 30; 64(11):31-35. PubMed ID: 30213286
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. MiR-34b-3 and miR-449a inhibit malignant progression of nasopharyngeal carcinoma by targeting lactate dehydrogenase A.
    Li H, Li X, Ge X, Jia L, Zhang Z, Fang R, Yang J, Liu J, Peng S, Zhou M, Xiang J, Zeng Z, Zhou W, Xiong W, Xiao G, Fang L, Li GY, Li Z.
    Oncotarget; 2016 Aug 23; 7(34):54838-54851. PubMed ID: 27458165
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. miR-30a-5p suppresses breast tumor growth and metastasis through inhibition of LDHA-mediated Warburg effect.
    Li L, Kang L, Zhao W, Feng Y, Liu W, Wang T, Mai H, Huang J, Chen S, Liang Y, Han J, Xu X, Ye Q.
    Cancer Lett; 2017 Aug 01; 400():89-98. PubMed ID: 28461244
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacological or genetic inhibition of LDHA reverses tumor progression of pediatric osteosarcoma.
    Gao S, Tu DN, Li H, Jiang JX, Cao X, You JB, Zhou XQ.
    Biomed Pharmacother; 2016 Jul 01; 81():388-393. PubMed ID: 27261617
    [Abstract] [Full Text] [Related]

  • 14. miR-200b is a key regulator of tumor progression and metabolism targeting lactate dehydrogenase A in human malignant glioma.
    Hu S, Jiang Q, Luo D, Zhao L, Fu X, Chen Y, Song X, Li L, Zhao H, He Y, Peng B.
    Oncotarget; 2016 Jul 26; 7(30):48423-48431. PubMed ID: 27374173
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. E2F1-Induced FTH1P3 Promoted Cell Viability and Glycolysis Through miR-377-3p/LDHA Axis in Laryngeal Squamous Cell Carcinoma.
    Zhao L, Zheng Y, Zhang L, Su L.
    Cancer Biother Radiopharm; 2022 May 26; 37(4):276-286. PubMed ID: 33571038
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. H19 promotes aerobic glycolysis, proliferation, and immune escape of gastric cancer cells through the microRNA-519d-3p/lactate dehydrogenase A axis.
    Sun L, Li J, Yan W, Yao Z, Wang R, Zhou X, Wu H, Zhang G, Shi T, Chen W.
    Cancer Sci; 2021 Jun 26; 112(6):2245-2259. PubMed ID: 33756038
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.